Dr. Conklin is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
310 S Penn St
Suite 105
Aberdeen, SD 57401Phone+1 605-622-8700Fax+1 605-622-5056
Education & Training
- University of Oklahoma Health Sciences CenterFellowship, Hematology and Medical Oncology, 1986 - 1989
- University of Oklahoma Health Sciences CenterResidency, Internal Medicine, 1983 - 1986
- Vanderbilt University School of MedicineClass of 1983
Certifications & Licensure
- SD State Medical License 1989 - 2025
- ND State Medical License 2015 - 2022
- OK State Medical License 1984 - 1990
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-small Cell Lung Cancer That Was Removed By Surgery Start of enrollment: 2007 Jun 01
- Tamoxifen Citrate or Letrozole With or Without Bevacizumab in Treating Women With Stage IIIB or Stage IV Breast Cancer Start of enrollment: 2008 May 15
- Radiation Therapy With or Without Trastuzumab in Treating Women With Ductal Carcinoma In Situ Who Have Undergone Lumpectomy Start of enrollment: 2008 Nov 10
- Join now to see all
Publications & Presentations
PubMed
- 2 citationsThe impact of the affordable care act on breast cancer care in the USA: A multi-institutional analysis.Jessica A. Maxwell, Oleg Shats, Joshua Aldridge, Elizabeth Lyden, Amy Krie
The Breast Journal. 2019-09-01
Press Mentions
- New Cancer Facility Helps Continues Coach's LegacyJanuary 22nd, 2016
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: